A sample report by Clearstate

Unparalleled depth and actionable intelligence about China’s in-vitro diagnostics market

China has been aggressively implementing various policies to control healthcare costs. In recent years, volume-based procurement (VBP) has been one of the most impactful policies, significantly reshaping China’s IVD market landscape. How are policies expected to affect market demand and future growth across vital IVD segments—like centralised Dx, POC testing, molecular Dx and tissue Dx?

This sample report offers a glance at the granular insights and in-depth analysis awaiting you in the full Segment Trend Report about China’s IVD market.